Lv1
20 积分 2025-04-25 加入
Exogenous Epstein–Barr virus nuclear antigen 1 induces ADAR1-driven tumor resistance against immunotherapy
2个月前
已完结
Metastatic SMARCA4-Deficient Undifferentiated Carcinoma of the Oral Cavity: A Case Report and Review of Literature
2个月前
已完结
SMARCA4-deficient Sinonasal Carcinoma
4个月前
已完结
Evolving landscape of nasopharyngeal carcinoma therapy
6个月前
已完结
Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
6个月前
已完结
Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial
6个月前
已完结
Neoadjuvant and adjuvant toripalimab for locoregionally advanced nasopharyngeal carcinoma: a randomised, single-centre, double-blind, placebo-controlled, phase 2 trial
6个月前
已完结
Epstein–Barr virus as a potentiator of autoimmune diseases
7个月前
已完结
Achieving control of nasopharyngeal carcinoma: the role of Epstein–Barr virus-based screening and vaccines
7个月前
已完结
皖公网安备34019202002308
